The study evaluated the clinical efficacy of MVC in terms of CD4 recovery,viral replication and tolerability in INR pts.
Efficacy of Maraviroc (MVC) as intensification strategy in immunological non-responder(INR) HIV-1-infected patients treated with HAART
FRANCISCI, Daniela;
2010
Abstract
The study evaluated the clinical efficacy of MVC in terms of CD4 recovery,viral replication and tolerability in INR pts.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
